Search research articles
Contact Us
Filters
Showing results (611-620 of 685) with videos related to
Page
of 69
Sort By:
International Journal of Molecular Sciences
|
March 10, 2022
Extracellular Vesicles Secreted by Glioma Stem Cells Are Involved in Radiation Resistance and Glioma Progression
Chenkai Ma, Hong P T Nguyen, Jordan J Jones, et al.
British Journal of Cancer
|
July 3, 2008
In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs
D M Ashley, C D Riffkin, M M Lovric, et al.
Experimental Cell Research
|
December 19, 2018
Cell quiescence correlates with enhanced glioblastoma cell invasion and cytotoxic resistance
Ryan J Atkins, Stanley S Stylli, Natalie Kurganovs, et al.
Science (New York, N.Y.)
|
June 24, 1977
Neurometrics
E R John, B Z Karmel, W C Corning, et al.
Biological Psychiatry
|
January 24, 2007
Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa
Ursula F Bailer, Guido K Frank, Shannan E Henry, et al.
The International Journal of Eating Disorders
|
March 5, 2009
Sexual functioning in women with eating disorders
Andréa Poyastro Pinheiro, T J Raney, Laura M Thornton, et al.
Archives of General Psychiatry
|
September 7, 2005
Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635
Ursula F Bailer, Guido K Frank, Shannan E Henry, et al.
Psychiatry Research
|
November 17, 2012
Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa
Ursula F Bailer, Guido K Frank, Julie C Price, et al.
Cell Reports
|
June 15, 2026
Convergent molecular signatures across eating disorders and obsessive-compulsive disorder in the human brain
Michael S Breen, Ran Tao, Andy Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma
K Clarke, R L Basser, C Underhill, et al.
Page
of 69
Search research articles
Search
Showing results (611-620 of 685) with videos related to
Sort By:
Page
of 69
International Journal of Molecular Sciences
|
March 10, 2022
Extracellular Vesicles Secreted by Glioma Stem Cells Are Involved in Radiation Resistance and Glioma Progression
Chenkai Ma, Hong P T Nguyen, Jordan J Jones, et al.
British Journal of Cancer
|
July 3, 2008
In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs
D M Ashley, C D Riffkin, M M Lovric, et al.
Experimental Cell Research
|
December 19, 2018
Cell quiescence correlates with enhanced glioblastoma cell invasion and cytotoxic resistance
Ryan J Atkins, Stanley S Stylli, Natalie Kurganovs, et al.
Science (New York, N.Y.)
|
June 24, 1977
Neurometrics
E R John, B Z Karmel, W C Corning, et al.
Biological Psychiatry
|
January 24, 2007
Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa
Ursula F Bailer, Guido K Frank, Shannan E Henry, et al.
The International Journal of Eating Disorders
|
March 5, 2009
Sexual functioning in women with eating disorders
Andréa Poyastro Pinheiro, T J Raney, Laura M Thornton, et al.
Archives of General Psychiatry
|
September 7, 2005
Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635
Ursula F Bailer, Guido K Frank, Shannan E Henry, et al.
Psychiatry Research
|
November 17, 2012
Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa
Ursula F Bailer, Guido K Frank, Julie C Price, et al.
Cell Reports
|
June 15, 2026
Convergent molecular signatures across eating disorders and obsessive-compulsive disorder in the human brain
Michael S Breen, Ran Tao, Andy Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma
K Clarke, R L Basser, C Underhill, et al.
Page
of 69